Assessment of the dopaminergic lesion in Parkinson's disease by CSF markers.
LeWitt
P A
PA
Department of Neurology, Wayne State University School of Medicine, Detroit, Michigan.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000134:cerebrospinal fluid*; D001921:Brain / Q000503:physiopathology; D004298:Dopamine / Q000502:physiology*; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid*; D006801:Humans; D007980:Levodopa / Q000134:cerebrospinal fluid*; D009474:Neurons / Q000502:physiology; D010300:Parkinson Disease / Q000175:diagnosis / Q000503:physiopathology*
D015102:3,4-Dihydroxyphenylacetic Acid; D007980:Levodopa; D004298:Dopamine; D006719:Homovanillic Acid